Phase I safety andpharmacokineticsstudy ofrovalpituzumabtesirine in Japanesepatients withadvanced, recurrentsmall cell lungcancer Hibiki UdagawaHiroaki AkamatsuKentaro Tanaka2019 год

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
статья из журнала